bioRxivNeurosciencePreprint
Neuroprotective potential of an Ayurvedic compound "Ras Sindoor" on Drosophila melanogaster model of Parkinson's disease
Sonia Narwal, Arushi Rai, Shreyas IyeriD, Kirti Tare, Meghana TareiD
Abstract
Parkinsons Disease (PD) is the second most common neurodegenerative disease affecting 1-2% of the global population with no cure to date. PD is characterized by accumulation of Lewy Bodies (LBs), which are caused due to aggregation of incorrectly folded -Synuclein, (SNCA). Another form of PD manifestation is characterized by loss of function of parkin, which encodes an E3 ubiquitin ligase. Despite extensive research, the cause for onset and progression of PD remains unknown and current therapeutics mainly help manage the disease. An alternative line of treatment can be useful. In this study, we have employed two different genetic models of Drosophila to screen for Ayurvedic compounds and found an Ayurvedic mercury based organo-metallic drug Ras-Sindoor has neuroprotective function. Our data indicate that characteristic locomotory dysfunction phenotype of PD is restored upon administration of the compound. Interestingly, RS fed flies also exhibit reduced transcript levels of initiator caspase dronc, which possibly prevents cell death in dopaminergic neurons. Additionally, RS fed PD model flies exhibit an enhanced life span. Our studies emphasize beneficial use of traditional Ayurvedic compounds as a holistic cure for PD like multifactorial diseases.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Protective effects of saffron and its constituent crocetin to motor symptoms, short life span and rough-eyed phenotypes in the fly models of Parkinson's disease in vivo
- Genipin Alleviates Sleep Deficiencies Caused by α-Synuclein Toxicity in a Drosophila melanogaster Model of Parkinsons Disease
Olivia M. Davis, Alice H. Sappenfield, Robert Fairman·bioRxiv·Jul 21, 2026
- Disease-modifying effects of Vincamine supplementation in Drosophila and human cell models of Parkinson's disease
F. Sanz, Cristina Solana‐Manrique, Nuria Paricio·bioRxiv·Dec 28, 2022
- Genetic screening identifies glial adenosine as a therapeutic target in alpha-synucleinopathy
Maggie Sodders, E Okorie, … Abby L. Olsen·bioRxiv·May 15, 2024
- SNCAE46K transgenic Drosophila Model of Parkinsons Disease Confirmed the Causative Role of Oxidative Stress
Samaneh Reiszadeh Jahromi, S. R. Ramesh, … Mohammad Haddadi·bioRxiv·Feb 28, 2020
- Lysosome-acidifying nanoparticles rescue A30P α-synuclein induced neuronal death in cellular and Drosophila models of Parkinson's disease
Chih Hung Lo, Mengda Ren, … Jialiu Zeng·Advanced Healthcare MaterialsPeer-reviewed·Apr 25, 2026